Milnacipran

CHEMBL259209 Phase 4 Approuvé Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

246.4 g/mol

LogP

1.4

Phase

4

This antidepressant and pain-modifying medication increases the levels of serotonin and norepinephrine in the brain, helping to improve mood and reduce pain signals. It is used to treat depression and fibromyalgia-related chronic widespread pain.

Masse moléculaire

246,3500 g/mol

LogP

1,40

TPSA

46,30 Å²

Règle des 5 de Lipinski

Conforme

Aires thérapeutiques

Pain Management Rheumatoid Arthritis Migraine Generalized Anxiety Disorder Systemic Lupus Erythematosus Stroke Major Depressive Disorder Chronic Pain

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CCN(CC)C(=O)C1(c2ccccc2)CC1CN

InChI

InChI=1S/C15H22N2O/c1-3-17(4-2)14(18)15(10-13(15)11-16)12-8-6-5-7-9-12/h5-9,13H,3-4,10-11,16H2,1-2H3

Molecular Formula

C15H22N2O

HBD / HBA

1 / 2

Liaisons Rotatives

5

Atomes Lourds

18

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

This antidepressant and pain-modifying medication increases the levels of serotonin and norepinephrine in the brain, helping to improve mood and reduce pain signals. It is used to treat depression and fibromyalgia-related chronic widespread pain.

Yes, Milnacipran is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL259209. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 65833. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Vous cherchez des informations accessibles aux patients ?

Milnacipran sur PillFYI

Structure

Données Clés

Formule: C15H22N2O
Synonymes: 1

Liens externes

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.